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Pultnonary complications represent a major cause of
morbidity and mortality in immunosuppressed patients
(IP). The varied etiologies of pulmonary disease in IPs
include pyogenic, mycobacterial and opportunistic in-
fections, drug-induced pulmonary interstitial fibrosis,
pulmonary parenchymal involvement by the underlying
disease process, and intrapulmonary hemorrhage. With
the increasing use of corticosteroid and cytotoxic
therapy in a variety of nonmalignant diseases, such as
vasculitis, dermatomyositis, connective tissue disorders,
pemphigus vulgaris, chronic active hepatitis, and others,
recognition of the potential complications associated
with their use is imperative.
Unusual and fulminant infections may complicate
immunosuppressive therapy, Corticosteroid drugs im-
pair host defenses by several mechanisms, including
lymphocyte depletion, defective cellular imrriunity, in-
hibition of macrophage migration and phagocytosis, and
polymorphonuclear leukocyte dysfunction.' Prolonged
corticosteroid therapy in animals may predispose to se-
vere fungal and protozoan infections.^••' Alkylating
agents and azothiaprine similarly p.edispose to infecti-
ous complications, primarily by their effects on reducing
granuiocyte number.''
The development of pulmonary infiltrates in IP re-
quires urgent and aggressive evaluation, since infections
may rapidly overwhelm a host with impaired defenses.
Delay in therapy by only a few days may preclude a
successful outcome. However, the empiric use of multi-
ple antimicrobial and antimycotic agents to cover all
possible infectious etiologies may be hazardous due to
the potential toxic effects of these drugs. The serious
toxicity of antifungal therapy with amphotericin B makes
empiric therapy in undiagnosed infections inadvisable.
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although its value in documented fungal infections is
unquestioned. This review summarizes the major infec-
tious and noninfectious pulmonary complications seen
in IPs, with emphasis on clinical manifestations, differen-
tial diagnosis, diagnostic evaluation, and management.
Bacterial Pneumonia
Pneumonia represents the major cause of morbidity
and mortality in immunocompromised host, '̂̂  Although
the incidence of fungal and opportunistic infections are
higher in this population, bacteria remain the most
common causative agents,"-^ Several features differ-
entiate bacterial pneumonia in IPs from normal hosts:
the higher mortality,* greater incidence of gram-negative
organisms,®-̂  and relative dearth of physical findings of
pneumonia in IPs,^'-' The predominance of gram-
negative organisms in patients with neoplasia is affirmed
by demonstrating 217 gram-negative pneumonias out of
a total of 243 bacillary pneumonias seen in one cancer
hospital over a six-year period.** Although fever was
present in 195 of 21 7 gram-negative pneumonias, cough
and sputum production were present in a minority."
Further, physical findings were scanty, and findings of
consolidation were present in only 18%, Roentgeno-
grams rarely exhibited the classical lobar pattern typical
of normal hosts with bacterial suppurative infection, and
frequently involved multiple lobes bilaterally. Diagnosis
was further impeded by the scarcity of roentgenographic
findings in neutropenic patients, presumably related to
their inability to mount an inflammatory response. The
high incidence of bacteremia (32%) in that series em-
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phasizes the importance of obtaining blood cultures in
all IPs with pneumonia.
Others have affirmed the frequent lack of classic signs
and symptoms in IPs,® Although fever was present in
98% of 52 cases of pneumonia in acute leukemia pa-
tients, cough and sputum production were noted in less
than two-thirds, and consolidation, in a minority.
Sputum was produced in only 30 of 52 episodes of
pneumonia, and polymorphonuclear leukocytes were
usually scarce. However, the gram stain was quite accu-
rate in suggesting the causative organism(s).
Although the prognosis is generally better with gram-
positive pneumonias,'' the course in some IP can be ful-
minant. Reduction in corticosteroid or immunosuppres-
sive therapy may improve prognosis in renal transplant
patients with severe bacterial pneumonia,'" Due to the
high mortality and morbidity from bacillary pneumonias
in IP, early coverage with antibiotics, reduction in de-
gree of immunosuppression, and granuiocyte transfu-
sions, when required, are indicated. Broad spectrum
parenteral therapy to include an aminoglycoside, as well
as aerobic and anaerobic coverage is indicated at the
onset of symptoms. Delaying therapy pending a defini-
tive cultural diagnosis is to be strongly discouraged.
Legionnaire's
Pulmonary infection with Legionella pneumophilia
may be more common in IPs, and tends to run a more
fulminant course," In 8 IPs with pneumonia caused by L
pheumophilia, the initial presentation was indistinguish-
able from other bacterial pneumonias," All had fever
and malaise, and all but one manifested chills. Although
most produced sputum, in only a single case were
sputum leukocytes increased. In all cases, sputum cul-
tures grew normal flora. Chest roentgenograms initially
showed patchy infiltrates limited to one lobe, with rapid
progression over the next few days to consolidation and
bilateral disease in the majority. Abscess formation oc-
curred in two, and four developed respiratory failure.
Diagnosis was made in four cases by open lung biopsy,
by either cultures or immunofluorescent antibody (FA)
testing, and in the others by cultures of bronchial wash-
ings, direct FA staining of sputum and bronchial wash-
ings, and concurrent serologic titer rises. Unlike normal
hosts, response to oral erythromycin was poor, but par-
enteral erythromycin was associated with a favorable
outcome. Further, in two patients responding slowly to
erythromycin, the addition of rifampin accelerated the
resolution. Hence, for IP with pneumonia, early diag-
nosis via invasive procedures or FA testing ior Legionella
should be considered. Empiric therapy with parenteral
erythromycin 500 mg every six hours is indicated in
such patients while awaiting biopsy, or in whom no
biopsy is planned. In those with a definitive diagnosis
showing a slow response to erythromycin, rifampin
should be added for its possible synergistic effect,
Pittsburgh Agent
The recent report of an acute purulent pneumonia in
two renal transplant recipients due to the newly de-
scribed "Pittsburgh Agent," '̂  emphasizes early recogni-
tion df hitherto unsuspected organisms causing infection
in IPs, Since standard cultural techniques may fail to
demonstrate the organism, specific FA stains of alveolar
exudate or lung tissue should be performed to confirm
the diagnosis. Although optimal therapy is not clear,
beta-lactam antibiotics, such as penicillin, cephalothin,
and cefoxitin appear to be effective in vitro,'^
Nocardiosis
Pulmonary infection with the gram-positive, partially
acid-fast coccobacilli of the Nocardia species can be
exceedingly difficult to diagnose. The organisms can be
difficult to visualize when gram stained, and are notori-
ously difficult to culture,^ Hence, sputum cultures are
usually negative. Positive blood cultures are exceedingly
rare, even with disseminated disease,^ Roentgeno-
graphic findings are variable, including lobar or segmen-
tal consolidation, extensive broncopneumonia with
multiple abscesses, focal nodules, cavities, or a miliary
pattern.^ Histopathology is variable, and can show
extensive suppurative disease with polymorphonuclear
leukocyte infiltration and abscess formation, or a
chronic granulomatous reaction with multinucleated
giant cells and mononuclear cells,^ Due to the low yield
of noninvasive techniques, open lung biopsy is fre-
quently required for definitive diagnosis, Sulfonamide
therapy is highly effective, but must be continued for 6 to
12 months to preclude relapses,̂
Fungal Infections
Fungal pneumonia in IPs can be highly lethal, with a
rapid course, tendency to disseminate, and extreme dif-
ficulty in making a definitive diagnosis antemortem.
Several factors appear to predispose to invasive mycotic
infection, including prolonged leukopenia, cortico-
steroid or cytotoxic drug therapy, and prolonged antibio-
tic therapy,'^''"
Aspergillus Species
Invasive aspergillosis is particularly difficult to diag-
nose due to extreme difficulty in identifying or culturing
the fungus antemortem. In one autopsy series of
leukemics, Aspergillus represented the most common
fungus identified during autopsy, but in none of the 10
cases were antemortem cultures positive, despite exten-
sive pneumonia or even dissemination." Others have
confirmed the unreliability of antemortem cultures in
No. 10 PULMONARY INFILTRATES Lynch 579
documented aspergillosis.*^ In 93 cases of Aspergillus
infection complicating neoplasia, cultures were positive
in only seven of 59 antemortem cultures of sputum,
throat, or tracheal secretions.'^ In no cases were blood,
urine, or cerebrospinal fluid (CSF) cultures positive, even
with dissemination of extensive cerebral infection.
Hence, demonstration of the characteristic acute
branching septate hyphae on hematoxylin-eosin or
methenamine-silver stained tissue sections of biopsy
material is generally required for diagnosis.
Aspergillus is a classic invader of the lung. Pulmonary
involvement was documented in 90 of 93 cases of inva-
sive Asperg;7/us infections reported by Meyer et al.'^ The
most common clinical pattern for aspergillus infection
was unremitting fever and persistent or increasing
pulmonary infiltrates despite antibiotic therapy. The
most common types of lung involvement are necrotizing
bronchopneumonia and hemorrhagic infarction^^ sec-
ondary to the strong propensity oi Aspergillus to invade
vasculature, with the development of in situ thromboses
and multiple infarcts. Aspergillus also commonly in-
vades the central nervous system (CNS) with abscess
formation.
In the presence of pulmonary infiltrates or CNS find-
ings, the isolation of Aspergillus species from any
cultural site should strongly suggest infection in IPs.
Repeated isolation or demonstration of aspergillus in his-
tologic sections mandates amphotericin B therapy.
FHowever, aspergillus can be a contaminant, and a single
isolation in the absence of clinical disease does not war-
rant therapy.
Phyc.omycetes
Phycomycetes resemble aspergillus by their propen-
sity to involve the lung and CNS, their predilection to
invade vasculature with intraluminal thromboses, and
the clinical hallmarks of hemoptysis and pulmonary in-
farction. Phycomycetes is notoriously difficult to culture
antemortem, even in tissue specimens. Of 21 patients
with pulmonary phycomycosis reported by Meyer, all
eight with antemortem cultures of respiratory secretions
were negative, and all 13 postmortem lung cultures were
negative, despite evidence of pulmonary phycomy-
cosis.'^ Hence, cultures are unreliable even with dis-
seminated or extensive pulmonary phycomycosis, and
invasive procedures to procure tissue for demonstration
of the classic, large, nonspecific hyphae are required in
most cases. Although mortality with invasive
phycomycosis is high, early therapy with amphotericin B
and/or surgical resection has been successful.'^
Candida Species
Infections with Candida species are among the most
common invasive mycoses in IPs. Predisposing factors to
the development of invasive candidiasis include pro-
found granulocytopenia, prolonged antibiotic therapy,
corticosteroids, the presence of gastrointestinal mucosal
lesions, and intravenous catheters.^ Pulmonary involve-
ment is frequent, and may occur as Candida infection
limited to the lung, or in the setting of disseminated
candidiasis. Unfortunately, the roentgenographic pattern
of candidial pneumonia is not specific, and may show
patchy bronchopneumonia, lobar consolidation,
nodules, cavities, or diffuse miliary mottling.^ Further,
none of the serologic tests are reliable in either diagnos-
ing or excluding candidiasis.^ Diagnosis of invasive can-
didiasis by cultures of respiratory secretions is extremely
unreliable, particularly in patients with prior antibiotic
therapy, because of the high colonization rate without
representing deep tissue invasion."* Although the pres-
ence of pseudohyphae on sputum is suggestive of deep
rather than superficial infection, this finding is not
wholly reliable. Hence, the most accurate way of diag-
nosing candidal pneumonia is the demonstration of
fungi invading pulmonary parenchyma on biopsy
specimens.* In cases where pulmonary parenchyma is
not obtained, a high probability of candidal pneumonia
can be inferred in the presence of signs of dissemination,
such as multiple positive blood cultures or cultures from
multiple sites. Culturing Candida from metastatic skin
abscesses, multiple blood cultures, or the finding of typi-
cal fluffy exudates on retinal exam makes dissemination
likely, and warrants treatment with amphotericin B.
Histoplasma capsulatum
The spectrum of histoplasrnosis ranges from benign
asymptomatic pneumonitis to fatal dissemination. Al-
though data are limited in patients with underlying im-
mune deficiency states, it seems clear that the risk of
fatal and/or disseminated histoplasmosis is higher in this
population.'*"^" Davies et al reported disseminated his-
toplasmosis in eight IPs, and noted the onset of spiking
fevers within three months of the initiation of cortico-
steroid therapy in five.'* The clinical picture was
nonspecific, but all had spiking fevers and no patient
produced sputum. None had any history or signs of
acute respiratory illness preceding dissemination. Al-
though in four cases the chest roentgenogram was nor-
mal at the onset of fever, all subsequently developed
abnormalities. The most common roentgenographic ap-
pearance was diffuse interstitial infiltrates, but diffuse
nodules were also seen. Serologies were diagnostic in
only one of four tested. The relatively high yield of cul-
tures of tissue and blood, in contradistinction to Asper-
gillus and Phycomycetes, however, is worth emphasiz-
ing. Blood cultures were positive for/-/, capsulatum in 4
of 7 patients, and bone marrow cultures were positive in
3 of 4 patients. Induced sputum and urine yielded pos-
580 INTERNATIONAL JOURNAL OF DERMATOLOGY December 1980 Vol. 19
itive results in 3 of 6 and 1 of 8 cases, respectively. The
high yield of cultured specimens is confirmed by a re-
cent report of 22 consecutive patients with disseminated
histoplasmosis undergoing trephine bone marrow
biopsy with cultures.'^ Bone marrow biopsy demon-
strated typical fungi in tissue in 15 patients, and cultures
were positive despite negative histology in an additional
four. Two additional biopsies showed granuloma
suggestive of fungal infection. The importance of per-
forming methenamine-silver stains in addition to
hematoxylin-eosin was demonstrated by finding that in 7
patients with negative hematoxylin-eosin stains, silver
stains demonstrated histoplasmosis.'^
Oropharyngeal ulcers and skin lesions are common in
disseminated histoplasmosis and should be sought and
biopsied, if present.̂ "
Cryptococcus
Cryptococcal infection is strikingly increased in IPs,
and dissemination is common. Pulmonary involvement
is seen in virtually all cases, and is generally manifested
as diffuse interstitial pneumonitis on roentgenogram.
The vast majority are febrile, and neurologic symptoms,
although sometimes subtle, may be present. '̂ Cultures of
blood, urine, and sputum are positive for 10-30% of all
cases, but the highest yield may be from CSE,̂ ' In 2 of 46
cases reported by Kaplan et al, initial diagnosis was
made by urine cultures,^' Histology may be variable,
and can show histiocytic-lymphocytic infiltration,
granulomas, or frank suppurative pneumonia with prom-
inent neutrophilic response and abscess formation.^'
Hence, careful cultural techniques and staining for fungi
with methenamine-silver should be performed in any
biopsy material obtained, regardless of histologic
appearance,
Theavailability of a latex-agglutination slide test for cryp-
tococcal antigen in sera may provide a rapid diagnosis,
with a sensitivity rate in excess of 90%,̂ ^ However, false-
negative tests can occur in the face of extensive infection,
and should not preclude invasive procedures to obtain
tissue in patients with a compatible clinical diagnosis.
Because of its strong propensity to invade the CNS, I umbar
puncture to include India ink staining for Cryptococcus
and cryptococcal antigen determination should be
performed in any IP with interstitial pneumonitis with
impaired mental status, neurologic find ings, or headache,
Blastomyces dermatitidis
Pulmonary blastomycosis in IPs can be a diagnostic
dilemma. Sputum cultures are frequently negative, and
serologies and skin tests are wholly unreliable,^''
Roentgenographic findings are nonspecific, and can in-
clude diffuse reticulonodular infiltrates, patchy bron-
chopneumonia, or lobar consolidation. Skin lesions fre-
quently accompany Blastomyces pulmonary infections
and should be cultured and biopsied, if present. The
propensity to invade the prostate gland makes prostatic
massage for culturing secretions and urine culture war-
ranted in suspected cases, Papanicolau's stain test of
sputum or bronchial washings may reveal the charac-
teristic Blastomyces organism.^^ When the above studies
are nondiagnostic, invasive techniques to obtain lung
parenchyma may be necessary,
Mycobacterial Infection
Mycobacterial infections are more common and can
be fulminant in IPs, In 201 tuberculous infections in pa-
tients with neoplasia, Kaplan noted a higher prevalence
rate, strikingly high mortality, and greater incidence of
dissemination in patients with lymphoreticular malig-
nancies. '̂' Eeld et al reported 59 cases of mycobacterial
disease complicating pregnancy, including 30 cases of
atypical mycobacteria.^^ In contrast to Kaplan's series,
dissemination only occurred in three cases.
Most large series of pulmonary infiltrates in IPs report
only occasional mycobacterial infections, however. In
two series of open lung biopsies in IPs, tuberculous in-
fections were found in 1 of 78^^ and 2 of 70^^ biopsies.
Similarly, data from transbronchoscopic biopsy proce-
dures confirm only two tuberculous infections in 190
In summary, although mycobacterial infection com-
plicating immunosuppression is uncommon, when it
occurs, it can be lethal. Since antituberculous therapy is
of low toxicity, empiric therapy in IPs with pulmonary
infiltrates can be considered while awaiting a definitive
diagnosis. However, biopsy procedures should be per-
formed, when possible, in IPs with pulmonary infiltrates
of unknown etiology, due to the strong likelihood of
other opportunistic or fungal agents,
Pneumocystis carinii
P. carinii is a common cause of diffuse bilateral infil-
trates in IPs.̂ "̂'*'' Typically, patients have fever, non-
productive cough, progressive dyspnea, hypoxemia, and
scanty auscultatory findings.-'^ Chest roentgenograms
classically show patchy reticulonodular infiltrates pro-
gressing to diffuse alveolar consolidation and air bron-
chograms,̂ ^ However, atypical features with unilateral
predominance, lobar or segmental consolidation, or
pseudonodular patterns, can rarely be seen.'*̂  Pleural ef-
fusions and lymphadenopathy are distinctly uncommon,
and cavitation is never seen.''® The clinical course varies
from an inapparent pneumonitis to fulminant respiratory
failure leading to death. Serologic testing is of no value.
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either in confirming or excluding the diagnosis.^^-^^
Since the organism has never been cultured, diagnosis
requires visualization of the typical cysts on
methenamine-silver stains of bronchial secretions or
biopsy material. The yield on sputum or tracheal aspi-
rates is extraordinarily low,^ '̂̂ ^ but bronchial brushings
reveal the organism in a majority of cases." Open lung
biopsy has a higher yield.''"-^^ Typical histologic features
include alveolar septal thickening, hyaline membranes,
and a foamy proteinaceous exudate filling alveolar
spaces.̂ '•̂ •' Treatment for P. carinii is effective if initiated
early, and survival is directly related to duration of
therapy with either pentamadine or a combination of
trimethaprim-sulfamethoxazole (TMP-SMZ).^* Since
TMP-SMZ has little morbidity, its empiric initiation in
suspected cases of pneumocystosis seems warranted.
Viral Pneumonitis
Cytomegalovirus (CMV), herpes simplex virus (HSV)
and varicella can cause pneumonia in IPs. The clinical
course of pneumonia due to these viruses is highly vari-
able, ranging from asymptomatic to fulminant respira-
tory insufficiency leading to death. The chest
roentgenogram is nonspecific and may show patchy
bronchopneumonia, diffuse interstitial pneumonitis, or
alveolar consolidation.^ Tachypnea, nonproductive
cough, dyspnea, and low-grade fever are classic, but not
uniformly present. Although skin lesions may be present
in pneumonia due to CMV and HSV, varicella
pneumonia invariably occurs in conjunction with typi-
cal skin lesions.'* Serologic tests are nonspecific, and
titer rises do not correlate with extent of pulmonary in-
volvement.^-'"' Intranuclear inclusions visualized on
Papaniculau's stain test of sputum may suggest the diag-
nosis, but due to the high incidence of coexistent infec-
tions with P. carinii, bacterial, and fungal pathogens,
invasive techniques to obtain pulmonary parenchyma
may be required. The definitive diagnosis of viral
pneumonia requires demonstration of characteristic
intranuclear inclusions within alveolar cells and/or con-
comitant viral isolation by culture.^ Therapy with
adenine arabinoside may be of benefit in extensive HSV
infection.^ Although no effective treatment is available
for CMV and varicella pneumonia, reducing the degree
of immunosuppression is recommended.''
As in the normal host, viral pneumonias due to in-
fluenza, parainfluenza, and adenovirus, can on occasion
be fulminant, with development of respiratory distress,
disseminated intravascular coagulation, and bron-
chiolitis obliterans.'" Roentgenograms may show diffuse
interstitial pneumonia, extensive consolidation, or both.
Striking changes of alveolar septal edema, inflamma-
tion, and interstitial fibrosis can occur."" Treatment is
supportive.
Pulmonary Toxicity
Pulmonary infiltrates, associated with dyspnea and
occasionally frank respiratory failure, may complicate
radiation therapy to the thorax.'*^ Chest roentgenograms
may show diffuse interstitial and alveolar infiltrates,
characteristically confined to the radiation portals and
not to anatomical boundaries."*^ Histologic features in-
clude atypical and hyperplastic alveolar lining cells,
hyaline membranes, septal thickening and infiltration
with mononuclear cells, and fibrosis.''^ These his-
topathologic changes, although characteristic of radia-
tion injury, are not specific and can be seen with a wide
range of etiologies, including P. carinii, viral, and drug-
induced pneumonitis.
A variety of cytotoxic agents, including busulfan,
bleomycin, methotrexate, cyclophosphamide,
6-mercaptopurine, azothiaprine, melphelan, BCNtJ,
and CCNU, can cause acute pneumonitis and chronic
interstitial fibrosis, occasionally progressing to fatal res-
piratory insufficiency.^^ Pulmonary disease induced by
these agents is clinically and roentgenographically indis-
tinguishable from interstitial pneumonitis of infectious
and other etiologies.
Busulfan can induce striking pulmonary toxicity, with
cough, dyspnea, and roentgenographic changes of
chronic interstitial pneumonitis with superimposed al-
veolar consolidation.''"' Busulfan is rather unique in its
strong propensity to induce striking cytologic dysplasia
in bronchial and alveolar epithelium, with the develop-
ment of atypical bizarre cells with hyperchromatic
nuclei.'*'* Finding these characteristic cells on sputum
cytology may suggest the diagnosis. The development of
busulfan-induced lung injury necessitates withdrawal of
the drug.
A syndrome of cough, exertional dyspnea, and infil-
trates on chest roentgenograms may be seen within 12
days to five years after initiation of methotrexate
therapy.""̂  Chest roentgenographic abnormalities may
include linear and reticulonodular infiltrates, wide-
spread alveolar filling, or diffuse nodules."*̂  Histology
demonstrates atypical alveolar lining cells, hyaline
membranes, interstitial infiltration, and occasional de-
squamation of cells into alveolar spaces.'*̂  Although se-
vere interstitial fibrosis can occur, resolution with dis-
continuance of methotrexate is the rule.''̂  The role of
steroids is controversial. In several cases, spontaneous
resolution has occurred despite continued administra-
tion of methotrexate. Due to the potential for irreversible
pulmonary fibrosis, and life-threatening pulmonary in-
sufficiency, however, it seems prudent to withhold
methotrexate in cases of presumed toxicity. Cortico-
steroids may have a role in fulminant severe cases, in an
attempt to attenuate the inflammatory and fibrotic re-
sponse. Unfortunately, no criteria reliably predict the
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development of methotrexate pneumonitis, and no cor-
relation has been found with duration or total dosage of
therapy.''•*
Other cytotoxic agents can induce similar acute and
chronic pneumonitis syndromes. The roentgenographic,
clinical, and histologic features are similar to those de-
scribed with busulfan and methotrexate. Discontinua-
tion of the drug implicated is recommended,
Chrysotherapy can rarely cause pulmonary injury.
Chest roentgenograms may show diffuse infiltrates, of
either interstitial or alveolar type, and fulminant respira-
tory failure can ensue,'*̂  Lung biopsies show changes
compatible with interstitial pneumonitis and fibrosis but
are in no way specific,"*^ In the presence of associated
signs of gold hypersensitivity such as exfoliative der-
matitis, stomatitis, anemia, or fever, pulmonary infil-
trates should be strongly considered as related to gold
toxicity and the drug should be discontinued. The ab-
sence of extrapulmonary signs, however, does not
exclude gold-induced lung injury. Although in some
cases peripheral lymphocytes transform in response to
gold,'*^ others have reported negative results,̂ ^ Spon-
taneous resolution concurrent with discontinuance of
gold therapy has been reported, while others have
required corticosteroid therapy,""̂  The exact role and
proper dosage of corticosteroids is uncertain due to the
paucity of well-documented cases,
Intrapulmonary Hemorrhage
Progressive dyspnea and diffuse pulmonary infiltrates
due to extensive intrapulmonary hemorrhage have been
reported in the absence of gross hemoptysis,^•'"' Al-
though bronchoalveolar lavage with return of bloody
lavage fluid and marked increase in stainable hemoside-
rin within alveolar macrophages has been advocated as
a diagnostic aide in occult pulmonary hemorrhage,'"'
positive results do not necessarily exclude infectious
processes causing hemorrhage (eg, necrotizing bron-
chopneumonia, invasive aspergillus and Mucormycosis)
and hence seem to be of limited clinical value. Occult
pulmonary hemorrhage was detected in 54% of all lungs
in one series of 50 consecutive leukemia patients at au-
topsy, but clinically significant hemorrhage was seen in
only three cases, generally in association with severe
thrombocytopenia,^ In the absence of severe coag-
ulopathy or thrombocytopenia, pulmonary infiltrates in
the IP due to intrapulmonary hemorrhage are rare,
Noninvasive Procedures
Routine serologies in the evaluation of pulmonary in-
filtrates in IPs are of little or no value. A large prospective
study of diffuse pulmonary infiltrates in IPs showed es-
sentially no discriminatory value of extensive serological
testing for CMV, HSV, influenza and other viruses,
Mycoplasma, Legionnaire's, P. carinii, Aspergillus, Can-
dida, Cryptococcus, and other fungi.^^ Others have con-
firmed the unreliability of serologic testing for detection
of P. carinii.^''
Several investigators have affirmed the lack of
specificity of the chest roentgenogram in the evaluation
of IPs,*'̂ '̂̂ ^ The rapidity of change of the roentgeno-
gram, the pattern of infiltrates, presence or absence of
cavitation, pleural effusion, adenopathy, and the like
may be sufficiently characteristic to render certain diag-
noses either likely or improbable, but should not be re-
lied upon to give a precise etiologic diagnosis. Although
Pennington noted the inability to predict the etiology of
infiltrates by the pattern on roentgenogram, he noted
certain trends: bacterial pneumonia frequently pre-
sented as local consolidation (9 of 11 cases), and in no
case displayed diffuse interstitial infiltrates.* Fungal dis-
ease displayed variable features, including consolida-
tion, cavities, and diffuse interstitial infiltrates,* Similarly,
the presence of cavities, pleural effusions, lym-
phadenopathy, or well-circumscribed nodules are suffi-
ciently uncommon in P. carinii pneumonitis to render
the diagnosis improbable,^ '̂̂ ^-^^
Hence, findings on chest roentgenogram may narrow
the etiological possibilities to an extent. Diffuse re-
ticulonodular infiltrates essentially excludes the diag-
nosis of bacterial pneumonia, and coverage with an-
tibiotics alone would be wholly inadequate. Conversely,
a well-circumscribed nodule or cavity is highly unlikely
to represent P. carinii, but is compatible with
mycobacterial, fungal, or bacterial causation.
Invasive Techniques
Since noninvasive techniques infrequently provide a
specific etiological diagnosis, invasive techniques to ob-
tain pulmonary parenchyma may be required. Although
open lung biopsy provides the highest yield of specific
diagnoses,̂ ^• '̂' the requirements for general anesthesia, a
thoracostomy tube, and potential for serious operative
complications preclude its routine use, Transbronchial
lung biopsy (TBB) utilizing the fiberoptic bronchoscope,
however, can be performed under local anesthesia with
minimal morbidity and a specific diagnostic yield of in
excess of 30-50%.«'28-3i.« JBB has been particularly
efficacious in the diagnosis of P, carinii pneumonitis^*"^'
as well as fungal diseases*'^^'^*'^" and underlying
neoplasm,^*~ '̂' Bronchial brushings in conjunction with
TBB may enhance the diagnostic yield.*-^*-^' Bronchial
brushings and cultural techniques utilizing a sheathed
catheter for accurate bacteriologic (noncontaminated)
cultures may permit better evaluation of bacterial
pneumonias when sputum production is minimal,"*^
In virtually all series, the most common TBB finding is
nonspecific inflammatory changes (NSC) or fibrosis,
seen in 32% to 45% of biopsies,̂ ^-^*'̂ !-'** The signifi-
cance of such changes is controversial. Although Poe et
al concluded that NSC are infrequently associated with
specific treatable diseases,̂ " we found that more aggres-
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sive techniques led to specific treatable disorders in a
majority of cases,̂ ' In several such cases, the diagnosis
led to initiation of new and specific therapy which re-
sulted in recovery.
In summary, although fiberoptic bronchoscopy with
TBB permits a specific etiologic diagnosis in a minority
of cases, its low morbidity justifies its use as the initial
invasive diagnostic procedure in IP with pulmonary
infiltrates.
Summary
The approach to the IP with pulmonary infiltrates
should be both thorough and immediate. Vigorous
search for skin or mucous membrane lesions with ap-
propriate aspirate, biopsy, and cultural techniques may
permit early diagnosis. Sputum and blood cultures,
sputum gram stain, and Papanicolau smear to demon-
strate fungi, virocytes, or neoplastic cells should be per-
formed. In patients with neurological signs, lumbar
puncture to include cryptococcal antigen is indicated.
When disseminated fungal disease is a consideration,
urine cultures for fungi and bone marrow biopsy with
cultures should be performed within 24 hours of admis-
sion, Erythromycin and TMP-SMX therapy to cover for
Legionnaire's and P. carinii pneumonitis pending culture
results seems reasonable in any IP with pulmonary
infiltrates.
In patients with a clinical course compatible with
bacterial illness, empirical broad-spectrum antibiotics
should be begun immediately. Examination of sputum
gram stain may guide therapy if a predominant organism
is repeatedy visualized. In patients with a clinical diag-
nosis of bacterial pneumonia in whom response to an-
tibiotics is slow, transbronchial lung biopsy (TBB) with
cultures should be performed to guide therapy. If the
TBB is nondiagnostic and clinical response is in-
adequate, open lung biopsy should be performed.
In IPs with diffuse reticulonodular infiltrates, bacterial
infection is unlikely and parenteral antibiotics alone are
probably inadequate. Further, due to the low yield of
noninvasive techniques in such patients, TBB with spe-
cial stains for fungi, P. carinii, and mycobacteria should
be done within 24 hours of admission. If TBB is non-
diagnostic, unless other tests are definitive, open lung
biopsy is recommended within the next 48 to 96 hours
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